Use of tyrosine-arginine dipeptide and niacinamide as substance P antagonist
US8858968B2 · kind B2 · utility
3Cited by
2References
31Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 5, 2006 |
| Grant date | Oct 14, 2014 |
| Priority date | — |
| Expiry date | Apr 6, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Use of the combination of the tyrosine-arginine dipeptide or derivatives thereof and of niacinamide as a substance P antagonist for treating red blotches on the skin, skin oedema and sensitive skin. Use of this combination for the preparation of a composition for use in treating disorders associated with an excess synthesis and/or release of substance P.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.